A recent study has found that semaglutide injections, a drug commonly used for weight loss, can significantly reduce osteoarthritis symptoms, cutting pain levels by nearly 50%. Osteoarthritis is a degenerative joint disease that causes chronic pain and affects mobility. Semaglutide, a glucagon-like peptide-1 (GLP-1) drug, is known for weight loss and diabetes treatment but has shown promise in relieving osteoarthritis symptoms. In a trial involving obese participants with moderate knee osteoarthritis, those who received semaglutide injections lost significantly more weight and reported less pain compared to those who received a placebo. This suggests semaglutide could be a viable non-surgical treatment option for osteoarthritis in obese individuals.
Source link
Weight Loss Drugs Could Be A Treatment Option For Osteoarthritis: Says Study
